Published in Mol Cell Biol on September 01, 2004
Neuronal SH2B1 is essential for controlling energy and glucose homeostasis. J Clin Invest (2007) 2.42
Grb10 and Grb14: enigmatic regulators of insulin action--and more? Biochem J (2005) 1.88
Energy metabolism in the liver. Compr Physiol (2014) 1.88
Structural basis for inhibition of the insulin receptor by the adaptor protein Grb14. Mol Cell (2005) 1.84
SH2B regulation of growth, metabolism, and longevity in both insects and mammals. Cell Metab (2010) 1.34
The SH2B gene is associated with serum leptin and body fat in normal female twins. Obesity (Silver Spring) (2007) 1.30
SH2B1 enhances insulin sensitivity by both stimulating the insulin receptor and inhibiting tyrosine dephosphorylation of insulin receptor substrate proteins. Diabetes (2009) 1.28
Kinase activation through dimerization by human SH2-B. Mol Cell Biol (2005) 1.22
Molecular basis of signaling specificity of insulin and IGF receptors: neglected corners and recent advances. Front Endocrinol (Lausanne) (2012) 1.17
Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2. EMBO J (2006) 1.11
NF-κB–inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action. Nat Med (2012) 1.10
Genes and lifestyle factors in obesity: results from 12,462 subjects from MONICA/KORA. Int J Obes (Lond) (2010) 1.04
Dual ablation of Grb10 and Grb14 in mice reveals their combined role in regulation of insulin signaling and glucose homeostasis. Mol Endocrinol (2009) 1.04
Studies of metabolic phenotypic correlates of 15 obesity associated gene variants. PLoS One (2011) 1.03
Identification of SH2B2beta as an inhibitor for SH2B1- and SH2B2alpha-promoted Janus kinase-2 activation and insulin signaling. Endocrinology (2007) 1.03
Regulation of lifespan, metabolism, and stress responses by the Drosophila SH2B protein, Lnk. PLoS Genet (2010) 1.01
Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state. Mol Cell Biol (2006) 0.97
Molecular characterization of mutant mouse strains generated from the EUCOMM/KOMP-CSD ES cell resource. Mamm Genome (2013) 0.96
Critical role of the Src homology 2 (SH2) domain of neuronal SH2B1 in the regulation of body weight and glucose homeostasis in mice. Endocrinology (2010) 0.91
Laboratory mouse models for the human genome-wide associations. PLoS One (2010) 0.90
Adapter protein SH2B1beta cross-links actin filaments and regulates actin cytoskeleton. Mol Endocrinol (2009) 0.89
Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses. Diabetes (2012) 0.88
The SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cells. Atherosclerosis (2011) 0.86
Adapter protein SH2B1beta binds filamin A to regulate prolactin-dependent cytoskeletal reorganization and cell motility. Mol Endocrinol (2011) 0.85
SH2B1 in β-cells regulates glucose metabolism by promoting β-cell survival and islet expansion. Diabetes (2013) 0.84
New function of the adaptor protein SH2B1 in brain-derived neurotrophic factor-induced neurite outgrowth. PLoS One (2013) 0.83
Screening for coding variants in FTO and SH2B1 genes in Chinese patients with obesity. PLoS One (2013) 0.83
Adapter protein SH2-Bbeta stimulates actin-based motility of Listeria monocytogenes in a vasodilator-stimulated phosphoprotein (VASP)-dependent fashion. Infect Immun (2007) 0.81
Phosphorylation controls a dual-function polybasic nuclear localization sequence in the adapter protein SH2B1β to regulate its cellular function and distribution. J Cell Sci (2011) 0.81
The adaptor protein SH2B1β reduces hydrogen peroxide-induced cell death in PC12 cells and hippocampal neurons. J Mol Signal (2010) 0.80
SH2B1 regulation of energy balance, body weight, and glucose metabolism. World J Diabetes (2014) 0.79
Hepatic SH2B1 and SH2B2 regulate liver lipid metabolism and VLDL secretion in mice. PLoS One (2013) 0.79
Functional characterization of obesity-associated variants involving the α and β isoforms of human SH2B1. Endocrinology (2014) 0.77
SH2B1 in β-cells promotes insulin expression and glucose metabolism in mice. Mol Endocrinol (2014) 0.76
Insulin, longevity, and genetic analysis of metabolism. Protein Cell (2010) 0.75
Recent advances of adapter proteins in the regulation of heart diseases. Heart Fail Rev (2017) 0.75
Lyn mediates FIP1L1-PDGFRA signal pathway facilitating IL-5RA intracellular signal through FIP1L1-PDGFRA/JAK2/Lyn/Akt network complex in CEL. Oncotarget (2016) 0.75
A central role for JNK in obesity and insulin resistance. Nature (2002) 17.27
Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science (2001) 11.22
Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem (2002) 9.76
Disruption of IRS-2 causes type 2 diabetes in mice. Nature (1998) 7.94
The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem (2000) 7.41
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature (1991) 6.50
Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature (1994) 6.50
Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature (1994) 5.33
Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol (1994) 5.13
Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem (2001) 5.12
SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem (2002) 4.84
Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J (1997) 4.59
CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature (2000) 4.10
Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest (2001) 3.41
Role of IRS-2 in insulin and cytokine signalling. Nature (1995) 3.23
The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol Cell Biochem (1998) 3.00
Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature (2001) 2.77
IRS-2 pathways integrate female reproduction and energy homeostasis. Nature (2000) 2.45
c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem (2002) 2.45
The insulin signalling system and the IRS proteins. Diabetologia (1997) 2.44
Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases. J Biol Chem (2003) 2.30
Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins. J Biol Chem (1993) 1.96
Identification and characterization of novel substrates of Trk receptors in developing neurons. Neuron (1998) 1.84
Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling. Mol Cell Biol (1997) 1.82
Identification of SH2-bbeta as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2. Proc Natl Acad Sci U S A (1999) 1.79
APS facilitates c-Cbl tyrosine phosphorylation and GLUT4 translocation in response to insulin in 3T3-L1 adipocytes. Mol Cell Biol (2002) 1.52
Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2. J Biol Chem (2001) 1.45
SH2-Balpha is an insulin-receptor adapter protein and substrate that interacts with the activation loop of the insulin-receptor kinase. Biochem J (1998) 1.44
Structural basis for recruitment of the adaptor protein APS to the activated insulin receptor. Mol Cell (2003) 1.38
Identification of the APS protein as a novel insulin receptor substrate. J Biol Chem (1999) 1.30
SH2-B is required for nerve growth factor-induced neuronal differentiation. J Biol Chem (1999) 1.30
SH2-B and APS are multimeric adapters that augment TrkA signaling. Mol Cell Biol (2001) 1.29
SH2-B is required for both male and female reproduction. Mol Cell Biol (2002) 1.27
Four PSM/SH2-B alternative splice variants and their differential roles in mitogenesis. J Biol Chem (2001) 1.24
Inhibition of phosphatidylinositol 3-kinase activity by adenovirus-mediated gene transfer and its effect on insulin action. J Biol Chem (1998) 1.22
Platelet-derived growth factor (PDGF) stimulates the association of SH2-Bbeta with PDGF receptor and phosphorylation of SH2-Bbeta. J Biol Chem (1998) 1.22
Insulin-like growth factor-I receptor and insulin receptor association with a Src homology-2 domain-containing putative adapter. J Biol Chem (1998) 1.20
Phosphoinositide 3-kinase is required for insulin-induced but not for growth hormone- or hyperosmolarity-induced glucose uptake in 3T3-L1 adipocytes. Mol Endocrinol (1997) 1.19
YMXM motifs and signaling by an insulin receptor substrate 1 molecule without tyrosine phosphorylation sites. Mol Cell Biol (1996) 1.17
PSM, an insulin-dependent, pro-rich, PH, SH2 domain containing partner of the insulin receptor. J Biochem (1997) 1.16
Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation. J Biol Chem (2002) 1.15
Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. Mamm Genome (1999) 1.14
The APS adapter protein couples the insulin receptor to the phosphorylation of c-Cbl and facilitates ligand-stimulated ubiquitination of the insulin receptor. FEBS Lett (2000) 1.13
Increased insulin sensitivity and hypoinsulinemia in APS knockout mice. Diabetes (2003) 1.13
The roles of Cbl-b and c-Cbl in insulin-stimulated glucose transport. J Biol Chem (2003) 1.08
APS, an adapter protein with a PH and SH2 domain, is a substrate for the insulin receptor kinase. Biochem J (1999) 1.01
Wortmannin inhibits both insulin- and contraction-stimulated glucose uptake and transport in rat skeletal muscle. J Appl Physiol (1985) (1996) 1.01
Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem (2002) 9.76
Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem (2001) 5.12
SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem (2002) 4.84
Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest (2005) 4.81
Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science (2007) 4.80
The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest (2002) 4.05
Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. Mol Cell Biol (2005) 3.50
Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metab (2008) 3.22
Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding. Cell Metab (2009) 3.07
Effect of genome size on AAV vector packaging. Mol Ther (2009) 2.77
c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem (2002) 2.45
Neuronal SH2B1 is essential for controlling energy and glucose homeostasis. J Clin Invest (2007) 2.42
Regulation of glucose homeostasis through a XBP-1-FoxO1 interaction. Nat Med (2011) 2.40
Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest (2004) 2.34
RIP-Cre revisited, evidence for impairments of pancreatic beta-cell function. J Biol Chem (2005) 2.32
Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab (2009) 2.27
Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat Med (2005) 2.18
Insulin-like signaling, nutrient homeostasis, and life span. Annu Rev Physiol (2008) 2.07
Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice. Cell Metab (2005) 2.04
Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. J Neurosci (2003) 2.03
SH2B1 enhances leptin signaling by both Janus kinase 2 Tyr813 phosphorylation-dependent and -independent mechanisms. Mol Endocrinol (2007) 1.96
Pdx1 restores beta cell function in Irs2 knockout mice. J Clin Invest (2002) 1.95
Defective insulin secretion in pancreatic beta cells lacking type 1 IGF receptor. J Clin Invest (2002) 1.93
Foxo1 integrates insulin signaling with mitochondrial function in the liver. Nat Med (2009) 1.85
Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. J Clin Invest (2003) 1.83
Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth. J Clin Invest (2005) 1.80
Insulin signaling meets mitochondria in metabolism. Trends Endocrinol Metab (2010) 1.77
The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis. Mol Cell Biol (2009) 1.69
Structural and biochemical characterization of the KRLB region in insulin receptor substrate-2. Nat Struct Mol Biol (2008) 1.67
Irs1 serine 307 promotes insulin sensitivity in mice. Cell Metab (2010) 1.67
Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation. Biochem Biophys Res Commun (2004) 1.59
Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models. Antioxid Redox Signal (2010) 1.59
Identification of MUP1 as a regulator for glucose and lipid metabolism in mice. J Biol Chem (2009) 1.56
Involvement of insulin receptor substrate 2 in mammary tumor metastasis. Mol Cell Biol (2004) 1.55
Altered relationship of blood pressure to adiposity in hypertension. Am J Hypertens (2008) 1.54
SH2-B promotes insulin receptor substrate 1 (IRS1)- and IRS2-mediated activation of the phosphatidylinositol 3-kinase pathway in response to leptin. J Biol Chem (2004) 1.51
Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function. J Biol Chem (2005) 1.51
Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes. Diabetes (2003) 1.51
Nutrient-dependent and insulin-stimulated phosphorylation of insulin receptor substrate-1 on serine 302 correlates with increased insulin signaling. J Biol Chem (2003) 1.47
Pedicled deep inferior epigastric perforator flap: an alternative method to repair groin and scrotal defects. Ann Plast Surg (2006) 1.43
Genetic deficiency of glycogen synthase kinase-3beta corrects diabetes in mouse models of insulin resistance. PLoS Biol (2008) 1.40
Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness. Cancer Sci (2007) 1.35
Interleukin-4-mediated protection of primary B cells from apoptosis through Stat6-dependent up-regulation of Bcl-xL. J Biol Chem (2002) 1.34
SH2B regulation of growth, metabolism, and longevity in both insects and mammals. Cell Metab (2010) 1.34
Pulsatile portal vein insulin delivery enhances hepatic insulin action and signaling. Diabetes (2012) 1.32
Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications. Cancer Res (2002) 1.32
Targeted disruption of ROCK1 causes insulin resistance in vivo. J Biol Chem (2009) 1.31
Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice. Hepatology (2009) 1.31
SH2B1 enhances insulin sensitivity by both stimulating the insulin receptor and inhibiting tyrosine dephosphorylation of insulin receptor substrate proteins. Diabetes (2009) 1.28
Stat6 and IRS-2 cooperate in interleukin 4 (IL-4)-induced proliferation and differentiation but are dispensable for IL-4-dependent rescue from apoptosis. Mol Cell Biol (2002) 1.21
Suppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis. Mol Cell Biol (2006) 1.19
Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice. Diabetes (2004) 1.18
PKA phosphorylation couples hepatic inositol-requiring enzyme 1alpha to glucagon signaling in glucose metabolism. Proc Natl Acad Sci U S A (2011) 1.17
Overexpression or ablation of JNK in skeletal muscle has no effect on glycogen synthase activity. Am J Physiol Cell Physiol (2004) 1.16
The repression of IRS2 gene by ATF3, a stress-inducible gene, contributes to pancreatic beta-cell apoptosis. Diabetes (2007) 1.15
Myocardial loss of IRS1 and IRS2 causes heart failure and is controlled by p38α MAPK during insulin resistance. Diabetes (2013) 1.14
IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease. J Clin Invest (2011) 1.14
Differential role of SH2-B and APS in regulating energy and glucose homeostasis. Endocrinology (2006) 1.13
Chronic activation of a designer G(q)-coupled receptor improves β cell function. J Clin Invest (2013) 1.13
Evaluation of the association between maternal smoking, childhood obesity, and metabolic disorders: a national toxicology program workshop review. Environ Health Perspect (2012) 1.13
Insulin receptor substrates Irs1 and Irs2 coordinate skeletal muscle growth and metabolism via the Akt and AMPK pathways. Mol Cell Biol (2010) 1.13
Direct autocrine action of insulin on β-cells: does it make physiological sense? Diabetes (2013) 1.12
Insulin receptor substrate proteins and diabetes. Arch Pharm Res (2004) 1.12
NF-κB–inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action. Nat Med (2012) 1.10
Transcriptional repressor E4-binding protein 4 (E4BP4) regulates metabolic hormone fibroblast growth factor 21 (FGF21) during circadian cycles and feeding. J Biol Chem (2010) 1.08
The reciprocal stability of FOXO1 and IRS2 creates a regulatory circuit that controls insulin signaling. Mol Endocrinol (2006) 1.08
Leptin signaling and leptin resistance. Front Med (2013) 1.08
Signaling pathways: the benefits of good communication. Curr Biol (2004) 1.04
Identification of SH2B2beta as an inhibitor for SH2B1- and SH2B2alpha-promoted Janus kinase-2 activation and insulin signaling. Endocrinology (2007) 1.03
Leptin stimulates both JAK2-dependent and JAK2-independent signaling pathways. J Biol Chem (2008) 1.02
Human SH2B1 mutations are associated with maladaptive behaviors and obesity. J Clin Invest (2012) 1.01
Phosphatase and tensin homolog regulation of islet growth and glucose homeostasis. J Biol Chem (2005) 1.00
Insulin receptor substrate 2 is essential for maturation and survival of photoreceptor cells. J Neurosci (2005) 1.00
IRS-2 mediates the antiapoptotic effect of insulin in neonatal hepatocytes. Hepatology (2004) 0.98
Phosphorylation of Irs1 at SER-522 inhibits insulin signaling. Mol Endocrinol (2007) 0.98
Lipocalin-13 regulates glucose metabolism by both insulin-dependent and insulin-independent mechanisms. Mol Cell Biol (2010) 0.98
Insulin receptor substrate signaling suppresses neonatal autophagy in the heart. J Clin Invest (2013) 0.97
Simian rotaviruses possess divergent gene constellations that originated from interspecies transmission and reassortment. J Virol (2009) 0.96
Major urinary protein regulation of chemical communication and nutrient metabolism. Vitam Horm (2010) 0.95
IRS2 signaling in LepR-b neurons suppresses FoxO1 to control energy balance independently of leptin action. Cell Metab (2012) 0.95
Combination therapy with antiangiogenic treatment and photodynamic therapy for the nude mouse bearing U87 glioblastoma. Photochem Photobiol (2008) 0.94
The AKTion in non-canonical insulin signaling. Nat Med (2012) 0.94
Inhibition of insulin signaling in endothelial cells by protein kinase C-induced phosphorylation of p85 subunit of phosphatidylinositol 3-kinase (PI3K). J Biol Chem (2011) 0.93
Mouse hepatocyte overexpression of NF-κB-inducing kinase (NIK) triggers fatal macrophage-dependent liver injury and fibrosis. Hepatology (2014) 0.93
Feedback regulation of hepatic gluconeogenesis through modulation of SHP/Nr0b2 gene expression by Sirt1 and FoxO1. Am J Physiol Endocrinol Metab (2010) 0.93
Leptin promotes dopamine transporter and tyrosine hydroxylase activity in the nucleus accumbens of Sprague-Dawley rats. J Neurochem (2010) 0.93
Serine phosphorylation sites on IRS2 activated by angiotensin II and protein kinase C to induce selective insulin resistance in endothelial cells. Mol Cell Biol (2013) 0.92
Insulin signaling after exercise in insulin receptor substrate-2-deficient mice. Diabetes (2002) 0.92
Rice straw fermentation using lactic acid bacteria. Bioresour Technol (2007) 0.92
CEACAM6 attenuates adenovirus infection by antagonizing viral trafficking in cancer cells. J Clin Invest (2009) 0.92
Insulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation. J Biol Chem (2014) 0.92
Critical role of the Src homology 2 (SH2) domain of neuronal SH2B1 in the regulation of body weight and glucose homeostasis in mice. Endocrinology (2010) 0.91
Shp2 controls female body weight and energy balance by integrating leptin and estrogen signals. Mol Cell Biol (2012) 0.90
Insulin receptor substrate-2 in beta-cells decreases diabetes in nonobese diabetic mice. Endocrinology (2009) 0.90
Significance of contrast extravasation in patients with pelvic fracture. J Trauma (2007) 0.89
Excess mortality caused by medical injury. Ann Fam Med (2006) 0.89
Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses. Diabetes (2012) 0.88
Inhibition of TNF-α improves the bladder dysfunction that is associated with type 2 diabetes. Diabetes (2012) 0.88
Nerve growth factor receptor TrkA, a new receptor in insulin signaling pathway in PC12 cells. J Biol Chem (2013) 0.88